GlassScriptPhysician profile
Hansraj K Sheth
NPI 1558359265
$7,526.00
in general payments reported to CMS, 2019-2025
49 companies · $2,156 in 2025
The $2,156 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $59.08 · 2021: $270 · 2022: $545 · 2023: $1,210 · 2024: $2,264 · 2025: $2,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,509 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,508.74 |
| Education | $120.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,056.72 | 2019-2025 | Renasys Go V2 Home, Pico, Collagenase Santyl |
| Organogenesis INC. | $860.41 | 2019-2025 | Puraply Wound Matrix, Puraply, Cygnus Dual |
| Lilly USA, LLC | $622.67 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Collegium Pharmaceutical, INC. | $501.89 | 2023-2025 | Belbuca, Nucynta |
| Intuitive Surgical, INC. | $459.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $373.56 | 2024-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $302.10 | 2021-2025 | |
| Indivior INC. | $234.08 | 2024-2025 | Sublocade |
| Novo Nordisk INC | $202.95 | 2020-2025 | |
| Mimedx Group, INC. | $198.29 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $177.34 | 2023-2025 | Nuedexta, Rexulti |
| Alkermes, INC. | $169.63 | 2019-2025 | Vivitrol, Vivitrol |
| Heron Therapeutics, INC. | $163.04 | 2021-2024 | Zynrelef, Aponvie |
| Tela Bio, INC. | $131.20 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bioventus LLC | $131.10 | 2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hansraj Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.